UBS Loves This ‘AI Moat’ at Palantir. Why Analysts Still Think You Should Buy PLTR Stock
Palantir (PLTR) by Piotr Swat via Shutterstock According to UBS Group (UBS) analysts, the “ontology layer” of Palantir’s…
Pulmonary Arterial Hypertension Market: Expanding Revenue Landscape to 2034 – DelveInsight
The Key Pulmonary Arterial Hypertension Companies in the market include – Aerovate Therapeutics, Novartis, Keros Therapeutics, Vigonvita Life…
Cutaneous Squamous Cell Carcinoma Pipeline Grows as 45+ Pharma Companies Advance Novel Skin Cancer Therapies, Finds DelveInsight
“Cutaneous Squamous Cell Carcinoma (CSCC) – Pipeline Insight, 2026” DelveInsight’s “Cutaneous Squamous Cell Carcinoma (CSCC) – Pipeline Insight,…
ANGEL Wins Four Awards at the International Exhibition of Inventions Geneva Among Over 1,000 Entries
Geneva, Switzerland – 19 March, 2026 – the 51st International Exhibition of Inventions Geneva was held in Switzerland,…
The cattle charts are starting to get that Swiss cheese look, with gaps above and below the market.
Outside Markets & Headlines Outside markets have been choppy in the overnight trade, but stock indices are currently…
Unusual Options Activity Suggests the Smart Money Is Bullish About Rio Tinto Stock Despite Glencore Deal Collapse
As we head into the weekend and the second week of the Iran war, options volume is higher…
Paroxysmal Nocturnal Hemoglobinuria Market: Expanding Revenue Landscape to 2034 – DelveInsight
The Key Paroxysmal Nocturnal Hemoglobinuria Companies in the market include – Hoffmann-La Roche (Chugai Pharmaceutical), AstraZeneca (Alexion Pharmaceuticals),…
Is CB Outperforming the Financial Sector?
Chubb Limited phone and website-by T_Schneider via Shutterstock Headquartered in Zurich, Switzerland, Chubb Limited (CB) is a global…
Acinetobacter Infections Pipeline Expands as 7+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight
“Acinetobacter Infections – Pipeline Insight, 2026” DelveInsight’s “Acinetobacter Infections – Pipeline Insight, 2026” report provides comprehensive insights about…
Neuroendocrine Tumors Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Neuroendocrine Tumors pipeline constitutes 70+ key companies continuously…
What Are Wall Street Analysts’ Target Price for Chubb Limited Stock?
Chubb Limited office sign-by Poetra_ RH via Shutterstock Chubb Limited (CB) is a leading global insurance and reinsurance…
Should You Buy Nvidia Stock Before February 25? UBS Analysts Say ‘Yes.’
NVIDIA Corp logo outside building-by BING-JHEN_HONG via iStock Timothy Arcuri, an analyst at UBS, has called trading conditions…